sarcosine and docetaxel anhydrous

sarcosine has been researched along with docetaxel anhydrous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Battaglia, M; Bettocchi, C; Ditonno, P; Fanelli, M; Galleggiante, V; Germinario, CA; Larocca, AM; Lucarelli, G; Maiorano, E; Rutigliano, M; Selvaggi, FP; Spilotros, M; Vavallo, A	1

Other Studies

1 other study(ies) available for sarcosine and docetaxel anhydrous

Article	Year
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. Future oncology (London, England), 2013, Volume: 9, Issue:6 Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Castration; Disease-Free Survival; Docetaxel; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Proportional Hazards Models; Prostatic Neoplasms; Risk Factors; Sarcosine; Taxoids	2013

Article

Year

Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer.

Future oncology (London, England), 2013, Volume: 9, Issue:6

Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Castration; Disease-Free Survival; Docetaxel; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Proportional Hazards Models; Prostatic Neoplasms; Risk Factors; Sarcosine; Taxoids

2013